Login / Signup

Efflux in Gram-negative bacteria: what are the latest opportunities for drug discovery?

Teresa Gil-GilPablo LabordaLuz Edith Ochoa-SánchezJosé Luis MartínezSara Hernando-Amado
Published in: Expert opinion on drug discovery (2023)
Increasing the knowledge of the regulation, structure and function of efflux pumps provides information for the rational design of RND efflux pump inhibitors. These inhibitors would increase bacterial susceptibility to several antibiotics and, occasionally, will reduce bacterial virulence. Furthermore, the information on the effect that efflux pumps' overexpression has on bacterial physiology may serve to develop new anti-resistance strategies.
Keyphrases
  • drug discovery
  • healthcare
  • staphylococcus aureus
  • escherichia coli
  • cell proliferation
  • health information
  • transcription factor
  • cystic fibrosis
  • antimicrobial resistance